MedTrace Logo

Antegrade Arterial and Portal Flushing Versus Portal Flushing Only in LDLT

NCT03048318 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2017-06-29

No results posted yet for this study

Summary

Arterial flushing is a standard recommendation in deceased donor liver transplantation but not in living donor liver transplantation due to the risk of arterial intimal injury and short cold ischaemia time. There is recent evidence on benefit of retrograde arterial perfusion using hepatic venous occlusion and its benefits on post transplant cholestasis. However there is no data on antegrade arterial flushing.

Conditions

  • Biliary Complications
  • Graft Function, Delayed

Interventions

PROCEDURE

Arterial Flushing

PROCEDURE

Portal Flushing

Sponsors & Collaborators

  • Institute of Liver and Biliary Sciences, India

    lead OTHER

Principal Investigators

  • Rommel Sandhyav, MS · Institute of Liver and Biliary Sciences

  • Viniyendra Pamecha, MS, FRSS, FEBS · Professor

  • Senthil Kumar, MS, FRCS · Additional Professor

  • Shridhar Sasturkar, MS, MCh · Assistant Professor

  • Piyush Kumar Sinha, MS, MCh · Assistant Professor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2017-04-30
Completion
2017-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03048318 on ClinicalTrials.gov